Direct Healthcare Costs of Moderate and Severe Work-Related Injuries: Estimates from the National Trauma Center of Qatar.
Rafael J ConsunjiAhammed MekkodathilAyman El-MenyarAmber MehmoodBrijesh SathianAdnan A HyderNazia HiraniAisha AbeidHassan Al-ThaniRuben PeraltaPublished in: International journal of environmental research and public health (2022)
Work-related injuries (WRIs) are recognized as a leading cause of admission to the national trauma center of Qatar. A retrospective analysis of trauma registry data and electronic medical records was conducted on a cohort of all WRI patients who were admitted to the Hamad Trauma Center (HTC), in Doha, Qatar, between 2011 and 2017. A total of 3757 WRI patients were treated at the HTC over the 7-year study period. The overall cost for treatment was 124,671,431 USD (18 million USD per year), with a median cost of 19,071 USD. There was a strong positive correlation between the overall cost and hospital-stay cost (r 2 = 0.949, p = 0.00001) and between the overall cost and procedure cost (r 2 = 0.852, p = 0.00001). Motor vehicle crash (MVC) victims who wore seatbelts had significantly lower injury severity, hospital stay and median total costs. A comparison of patients by quartiles of the costs incurred showed that the proportions of MVC victims, pedestrian injuries and mortality were significantly higher in the fourth quartile when compared to other quartiles ( p < 0.05). These findings suggest that investments in the primary prevention of work-related injuries from falls and MVCs, through proven interventions, should be priorities for occupational safety and health in Qatar.
Keyphrases
- healthcare
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- emergency department
- public health
- type diabetes
- quality improvement
- mental health
- trauma patients
- climate change
- high intensity
- cardiovascular events
- cardiovascular disease
- big data
- early onset
- machine learning
- artificial intelligence
- smoking cessation
- adverse drug
- replacement therapy